The Boston course in Obesity Medicine 2023

Overview

The Boston Course in Obesity Medicine 2023 provides an updated professional education program reflecting the latest advances in obesity science and clinical practice. This course addresses recent developments including new therapies, clinical guidelines, and evolving models of care designed to improve the management of obesity and its complications.

On-demand Endocrinology & Metabolism education — accessible anytime, anywhere.

Format: 83 MP4 files
Total size: 31.03 GB

Content

This comprehensive course covers significant scientific and clinical advances in obesity medicine reported in the past year. Key topics include:

• SURMOUNT-1 study results on tirzepatide treatment for obesity demonstrating up to 22% average weight loss
• STEP TEENS study findings on semaglutide 2.4 mg weekly for adolescent obesity treatment showing approximately 17% average weight loss
• FDA approval of semaglutide 2.4 mg weekly for obesity in adolescents
• New American Academy of Pediatrics clinical practice guidelines for childhood and adolescent obesity
• Completion of the SELECT study on cardiovascular outcomes of semaglutide 2.4 mg weekly in patients with obesity without diabetes
• Institute for Clinical and Economic Review report on the utility and cost-effectiveness of anti-obesity medications
• Research uncovering mechanisms of resistance to weight loss with calorie reduction alone and GLP-1 receptor agonists’ role in blocking this resistance
• Investigations of adverse effects of highly processed foods
• Studies on timed feeding and intermittent fasting benefits and limitations
• Clinical and psychosocial consequences of weight-related bias, stigma, and discrimination
• Canadian clinical practice guidelines on obesity evaluation and management
• Phase 2 trial data on resmetirom showing resolution of NASH and fibrosis improvement
• New clinical practice guidelines for NAFLD and NASH evaluation and management
• Long-term cancer outcomes after bariatric surgery indicating significant improvements in cancer incidence and mortality
• Data demonstrating metabolic and bariatric surgery’s benefits on kidney disease markers
• Advances in optimizing metabolic and bariatric surgery safety and efficacy
• Updated clinical guidelines on selection and use of metabolic and bariatric surgery
• Evidence supporting endoscopic approaches for obesity, diabetes, and NAFLD treatment
• Benefits of combination and multimodal obesity treatments
• Development of new models for effective obesity care organization and dissemination
• Collaborative efforts to improve equitable access to obesity care
• The rise of startups streamlining access to effective obesity care
• Increasing payer and policymaker focus on the clinical and economic value of effective obesity treatment

Speakers

This course features expert presentations from leading clinicians, researchers, and policymakers involved in obesity medicine, offering insights relevant to clinical practice, health policy, and ongoing research advancements.

Target Audience

This course is designed for clinicians, researchers, policymakers, and healthcare professionals involved in obesity care, including endocrinologists, pediatricians, internal medicine specialists, and allied health providers seeking to update and expand their knowledge in obesity medicine.

Why This Topic Matters

The Boston Course in Obesity Medicine 2023 addresses critical developments in the field of obesity medicine, a rapidly advancing specialty within endocrinology and metabolism. It offers comprehensive updates on therapeutics, clinical guidelines, and care models essential for improving patient management.

Hosted on MedHub Central, this program supports clinicians and healthcare professionals in strengthening their expertise and confidence in obesity care, facilitating integration of current evidence into practice to address this common and complex condition.